Axogen Completes Acquisition of BioCircuit Technologies, Adding NerveTape™, the First FDA Cleared Device for Sutureless Peripheral Nerve Repair
Go back to Axogen Completes Acquisition of BioCircuit Technologies, Adding NerveTape™, the First FDA Cleared Device for Sutureless Peripheral Nerve Repair| AXOGEN (NASDAQ: AXGN) | Delayed: 37.17 +0.69 (1.89%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $36.48 | 52 Week High | $9.88 | |||
| Open | $36.48 | 52 Week Low | $4.52 | |||
| Day High | $37.21 | P/E | N/A | |||
| Day Low | $36.30 | EPS | $-1.18 | |||
| Volume | 226,786 | |||||



